Novel Mutations of Low-Density Lipoprotein Receptor Gene in China Patients with Familial Hypercholesterolemia

Applied Biochemistry and Biotechnology

Volumn 176, Issue 1, 2015, Pages 101-109

  Fan, Liang liang ^a   Lin, Min jie ^b   Chen, Ya qin ^b   Huang, Hao ^a   Peng, Dao quan ^b   Xia, Kun ^a   Zhao, Shui ping ^b   Xiang, Rong ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Familial hypercholesterolemia; LDLR; Mutation

Indexed keywords

DISEASES; GENE ENCODING; GENES; LIPOPROTEINS;

AUTOSOMAL DOMINANTS; CARDIOVASCULAR DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; GENETIC DIAGNOSIS; LDLR; LOW DENSITY LIPOPROTEIN RECEPTORS; LOW DENSITY LIPOPROTEINS; MUTATION;

DIAGNOSIS;

LOW DENSITY LIPOPROTEIN RECEPTOR; LDLR PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHINA; CHINESE; DNA SEQUENCE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE IDENTIFICATION; GENE MUTATION; GENETIC COUNSELING; GENETIC VARIABILITY; HUMAN; INVESTIGATIVE PROCEDURES; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIGENE FAMILY; PRESCHOOL CHILD; SCHOOL CHILD; ASIAN CONTINENTAL ANCESTRY GROUP; CLINICAL TRIAL; GENETICS; MUTATION; YOUNG ADULT;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; MUTATION; RECEPTORS, LDL; YOUNG ADULT;

EID: 84929703102     PISSN: 02732289     EISSN: 15590291     Source Type: Journal    
DOI: 10.1007/s12010-015-1554-x     Document Type: Article

References (28)

1. Lye, S. H., Chahil, J. K., Bagali, P., et al. (2013). Genetic polymorphisms in LDLR, APOB, PCSK9 and other lipid related genes associated with familial hypercholesterolemia in Malaysia. PLoS ONE, 8(4), e60729.
2. Hovingh, G. K., Davidson, M. H., Kastelein, J. J., & O'Connor, A. M. (2013). Diagnosis and treatment of familial hypercholesterolaemia. European Heart Journal, 34(13), 962–971.
3. Chiou, K. R., & Charng, M. J. (2012). Common mutations of familial hypercholesterolemia patients in Taiwan: characteristics and implications of migrations from southeast China. Gene, 498(1), 100–106.
4. Alicezah, M. K., Razali, R., Rahman, T., et al. (2014). Homozygous familial hypercholesterolemia. The Malaysian Journal of Pathology, 36(2), 131–137.
5. Mollaki, V., Progias, P., & Drogari, E. (2014). Familial hypercholesterolemia in Greek children and their families: genotype-to-phenotype correlations and a reconsideration of LDLR mutation spectrum. Atherosclerosis, 237(2), 798–804.
6. Mabuchi, H., Nohara, A., Noguchi, T., et al. (2014). Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutation. Atherosclerosis, 236(1), 54–61.
7. Alves, A. C., Etxebarria, A., Soutar, A. K., Martin, C., & Bourbon, M. (2014). Novel functional APOB mutations outside LDL-binding region causing familial hypercholesterolaemia. Human Molecular Genetics, 23(7), 1817–1828.
8. Hooper, A. J., Nguyen, L. T., Burnett, J. R., et al. (2012). Genetic analysis of familial hypercholesterolaemia in Western Australia. Atherosclerosis, 224(2), 430–434.
9. Costelloe, S. J., El-Sayed, M. J. S., Drenos, F., et al. (2012). Gene-targeted analysis of copy number variants identifies 3 novel associations with coronary heart disease traits. Circulation. Cardiovascular Genetics, 5(5), 555–560.
10. Kathiresan, S., Voight, B. F., Purcell, S., et al. (2009). Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nature Genetics, 41(3), 334–341.
11. Chiu, C. Y., Wu, Y. C., Jenq, S. F., & Jap, T. S. (2005). Mutations in low-density lipoprotein receptor gene as a cause of hypercholesterolemia in Taiwan. Metabolism, 54(8), 1082–1086.
12. Al-Rasadi, K., Al-Waili, K., Al-Zidi, W. A., et al. (2014). Low-density lipoprotein receptor gene mutation analysis and structure-function correlation in an Omani Arab family with familial hypercholesterolemia. Angiology, 65(10), 911–918.
13. Dai, Y. F., Sun, L. Y., Zhang, X. B., & Wang, L. Y. (2011). Research progression of LDLR mutations in Chinese familial hypercholesterolemia. Yi Chuan, 33(1), 1–8.
14. Xiang, R., Fan, L. L., Huang, H., et al. (2013). A novel mutation of GATA4 (K319E) is responsible for familial atrial septal defect and pulmonary valve stenosis. Gene.
15. Sunyaev, S., Ramensky, V., & Bork, P. (2000). Towards a structural basis of human non-synonymous single nucleotide polymorphisms. Trends in Genetics, 16(5), 198–200.
16. Ng, P. C., & Henikoff, S. (2003). SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Research, 31(13), 3812–3814.
17. Schwarz, J. M., Rodelsperger, C., Schuelke, M., & Seelow, D. (2010). MutationTaster evaluates disease-causing potential of sequence alterations. Nature Methods, 7(8), 575–576.
18. Robinson, J. G. (2013). Management of familial hypercholesterolemia: a review of the recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. Journal of Managed Care Pharmacy, 19(2), 139–149.
19. Chang, J. H., Pan, J. P., Tai, D. Y., et al. (2003). Identification and characterization of LDL receptor gene mutations in hyperlipidemic Chinese. Journal of Lipid Research, 44(10), 1850–1858.
20. Mak, Y. T., Pang, C. P., Tomlinson, B., et al. (1998). Mutations in the low-density lipoprotein receptor gene in Chinese familial hypercholesterolemia patients. Arteriosclerosis, Thrombosis, and Vascular Biology, 18(10), 1600–1605.
21. Jørgensen, A. B., Frikke-Schmidt, R., et al. (2014). Loss-of-function mutations in APOC3 and risk of ischemic vascular disease. The New England Journal of Medicine, 371(1), 32–41.
22. Lange, L. A., Hu, Y., Zhang, H., et al. (2014). Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol. The American Journal of Human Genetics, 94(2), 233–245.
23. Gent, J., & Braakman, I. (2004). Low-density lipoprotein receptor structure and folding. Cellular and Molecular Life Sciences, 61(19–20), 2461–2470.
24. Tan, Z. P., Xie, L., Deng, Y., et al. (2014). Whole-exome sequencing identifies Y1495X of SCN5A to be associated with familial conduction disease and sudden death. Scientific Reports, 4, 5616.
25. Mabuchi, H., Nohara, A., Noguchi, T., et al. (2011). Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan. Atherosclerosis, 214(2), 404–407.
26. Soufi, M., Rust, S., Walter, M., et al. (2013). A combined LDL receptor/LDL receptor adaptor protein 1 mutation as the cause for severe familial hypercholesterolemia. Gene, 521(1), 200–203.
27. Tosi, I., Toledo-Leiva, P., Neuwirth, C., et al. (2007). Genetic defects causing familial hypercholesterolaemia: identification of deletions and duplications in the LDL-receptor gene and summary of all mutations found in patients attending the Hammersmith Hospital Lipid Clinic. Atherosclerosis, 194(1), 102–111.
28. Bochem, A. E., Holleboom, A. G., Romijn, J. A., et al. (2014). Adrenal function in females with low plasma HDL-C due to mutations in ABCA1 and LCAT. PLoS ONE, 9(5), e90967.